LHON Main Diagnostic de la NOHL : sensibiliser le public à la souffran... Maryse Roger a vécu de près la neuropathie optique héréditaire de Leber (NOHL).
Views & Analysis LHON diagnosis: Opening peoples’ eyes to the invisible suffe... Maryse Roger has firsthand experience of Leber’s hereditary optic neuropathy (LHON), having first assisted her two brothers as their sight deteriorated and then leading the care of her son
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.